Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.


CSE:SONA - Post by User

Comment by Aarman4on Aug 14, 2020 6:27pm
600 Views
Post# 31410986

RE:RE:RE:RE:Insiders are NOT Selling

RE:RE:RE:RE:Insiders are NOT Selling
StockRV wrote: I've been in this stock since $1 and have enjoyed the ride so far. What is it that makes you think this stock can move two decimal places into the $1000 range? For me this sounds insane and very unrealistic but I am very new to trading overall and sona was one of my first big investments.



Welcome to the world of investing StockRV! Read LOTS of good books written by people like Peter Lynch, and Benjamin Graham to start.

Share price tends to reflect earnings in the long run. The share price trades at a multiple to earnings. Low multiples being a P/E of 5, high being considered anything usually above P/E of 30 . P/E can get really high with darling stocks that are growing very fast.

Earnings = Revenue(income) - Expenses(costs)

It is expected that Sona will be selling it's antigen test at a minimum of $25, with a (guessing)margin of roughly 66%. Let's call that $16.50 per test of profit.

Today the share price sits at $10/share, so to get to $1000 per share, the company would need to increase it's market cap(total shares X share price) from a current $608million to $60.8billion. No easy feat!

Simple math says that at low P/E of 10, a company must have earnings of $6.08billion in a yyear to achieve that valuation.

At $16.50 profit per test sold, SONA would need to sell roughly 368.5 million tests to hit that. I think this is actually VERY attainable.

Now, here is where it gets fun. Let's assume a high P/E (SONA will be a darling if it's sales take off) and give it a P/E of 30. This would push the share price to 30 times earnings, or a share price of roughly $3000 per share

OR

at P/E of 30, they need only sell roughly 122.8 million tests.

Fun to think of eh?

Hopefully that helps!

Cheers!


<< Previous
Bullboard Posts
Next >>